There really hasn't been as much news to move prices right now as you might think. The stigma of penny stocks still probably has most of the potential investors keeping THCZ at arms' length. They're not going to move until they see a good Q-10 (anyone even know if the auditing is finished yet?).

The Caveat Emptor might be gone from OTC Markets, but a lot of folks no doubt still have it in their minds.

I don't think much else can be done for the price without some solid sales numbers being published. The release of the Coconut Lime might do a little, temporarily anyway.